Filing Details

Accession Number:
0000950170-25-088895
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-06-23 14:39:22
Reporting Period:
2025-06-20
Filing Date:
2025-06-23
Accepted Time:
2025-06-23 14:39:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1160308 Savara Inc SVRA Pharmaceutical Preparations (2834) 841318182
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1307632 J Richard Hawkins One Summit Square,
1717 Langhorne Newtown Road, Suite 300
Langhorne PA 19047
No No No No
Transaction Summary
Purchased: 48,225 shares Avg. Price: $2.04 Total Value: $98,571.90
Number of Shares After Transactions: 115,466 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-06-20 48,225 $2.04 115,466 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price is a weighted average purchase price. The purchase prices ranged from $2.0345 to $2.045. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.